Reducing human suffering by detecting cancer earlier with patented technology
BioCurex's RECAF(tm) marker is found in all types of major cancers
  • Demo Video
  • Private Messages
  • Edit My Profile
  • View/Edit Portfolio

Email Updates

Search

AGORACOM News Flash

AGORACOM WIRE - MONDAY MAY 28TH, 2012

SONOMAX completes $3 million equity financing

FOCUS METALS (TSXV:FMS) Changes Its Name to Focus Graphite Inc. Read More   |   *SPONSOR

INTERNATIONAL PBX VENTURES (TSX:PBX) Signs Copaquire Joint Venture Option Agreement - $90M Potential Payment Read More

LOMIKO METALS (TSXV:LMR) Graphite and Zinc Price Outlook is Favourable Through 2013  Read More   |   *SPONSOR

 

 

Message: New York Times article

Generic_profile
Rank: [?]
Treasurer
Points: [?]
258
Rating: [?]
Votes: 5 Score: 2.8
  • Currently 2.8/5 Stars.
Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.

Re: The NY Times forgot to interview 7,900,000 people in 2007 that would disagree!

posted on Jul 20, 09 11:30AM

Great response. You should send that to the NY Times, Letter to the Editor. A Letter to the Editor appearing in the Times with cross references to BioCurex could be a great way to get more eyeballs on this company

New Message

Please login to post a reply

AGORACOM Quick Tips

Testimonials. Members Sure Love AGORACOM! ... Get On The List!

President's D.D.

New feature: Hub Presidents can add important links here.

Stock Quote